Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.

Grissom CK, Hirshberg EL, Dickerson JB, Brown SM, Lanspa MJ, Liu KD, Schoenfeld D, Tidswell M, Hite RD, Rock P, Miller RR 3rd, Morris AH; National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network.

Crit Care Med. 2015 Feb;43(2):288-95. doi: 10.1097/CCM.0000000000000715.

PMID:
25599463
2.

Personalized contact strategies and predictors of time to survey completion: analysis of two sequential randomized trials.

Dinglas VD, Huang M, Sepulveda KA, Pinedo M, Hopkins RO, Colantuoni E, Needham DM; NIH NHLBI ARDS Network.

BMC Med Res Methodol. 2015 Jan 9;15:5. doi: 10.1186/1471-2288-15-5.

3.

Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome.

Hsieh SJ, Zhuo H, Benowitz NL, Thompson BT, Liu KD, Matthay MA, Calfee CS; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network; National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Network.

Crit Care Med. 2014 Sep;42(9):2058-68. doi: 10.1097/CCM.0000000000000418.

PMID:
24942512
4.

Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, Douglas IS, deBoisblanc BP, Hough CL, Hite RD, Thompson BT.

N Engl J Med. 2014 Jun 5;370(23):2191-200. doi: 10.1056/NEJMoa1401520. Epub 2014 May 18.

5.

Risk factors for physical impairment after acute lung injury in a national, multicenter study.

Needham DM, Wozniak AW, Hough CL, Morris PE, Dinglas VD, Jackson JC, Mendez-Tellez PA, Shanholtz C, Ely EW, Colantuoni E, Hopkins RO; National Institutes of Health NHLBI ARDS Network.

Am J Respir Crit Care Med. 2014 May 15;189(10):1214-24. doi: 10.1164/rccm.201401-0158OC.

6.

Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ; Benefits of Universal Glove and Gown (BUGG) Investigators, Shahryar SK, Price CS, Gadbaw JJ, Drees M, Kett DH, Muñoz-Price LS, Jacob JT, Herwaldt LA, Sulis CA, Yokoe DS, Maragakis L, Lissauer ME, Zervos MJ, Warren DK, Carver RL, Anderson DJ, Calfee DP, Bowling JE, Safdar N.

JAMA. 2013 Oct 16;310(15):1571-80.

7.

Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up.

Needham DM, Dinglas VD, Morris PE, Jackson JC, Hough CL, Mendez-Tellez PA, Wozniak AW, Colantuoni E, Ely EW, Rice TW, Hopkins RO; NIH NHLBI ARDS Network.

Am J Respir Crit Care Med. 2013 Sep 1;188(5):567-76. doi: 10.1164/rccm.201304-0651OC.

8.

One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial.

Needham DM, Dinglas VD, Bienvenu OJ, Colantuoni E, Wozniak AW, Rice TW, Hopkins RO; NIH NHLBI ARDS Network.

BMJ. 2013 Mar 19;346:f1532. doi: 10.1136/bmj.f1532.

9.

Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial.

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock P.

JAMA. 2012 Feb 22;307(8):795-803. doi: 10.1001/jama.2012.137. Epub 2012 Feb 5.

10.

Female body image following acquired brain injury.

Howes HF, Edwards S, Benton D.

Brain Inj. 2005 Jun;19(6):403-15.

PMID:
16101263
11.

Male body image following acquired brain injury.

Howes H, Edwards S, Benton D.

Brain Inj. 2005 Feb;19(2):135-47.

PMID:
15841757
12.

Anticoccidial derivatives of 6-azauracil. 5. Potentiation by benzophenone side chains.

Carroll RD, Miller MW, Mylari BL, Chappel LR, Howes HL Jr, Lynch MJ, Lynch JE, Gupta SK, Rash JJ, Koch RC.

J Med Chem. 1983 Jan;26(1):96-100.

PMID:
6687479
13.

Anticoccidial derivatives of 6-azauracil. 4. A 1000-fold enhancement of potency by phenyl sulfide and phenyl sulfone side chains.

Miller MW, Mylari BL, Howes HL Jr, Figdor SK, Lynch MJ, Lynch JE, Gupta SK, Chappel LR, Koch RC.

J Med Chem. 1981 Nov;24(11):1337-42.

PMID:
6895527
14.

Anticoccidial derivatives of 6-azauracil. 3. Synthesis, high activity, and short plasma half-life of 1-phenyl-6-azauracils containing sulfonamide substituents.

Miller MW, Mylari BL, Howes HL Jr, Figdor SK, Lynch MJ, Lynch JE, Koch RC.

J Med Chem. 1980 Oct;23(10):1083-7.

PMID:
6893468
15.

Anticoccidial derivatives of 6-azauracil. 2. High potency and long plasma life of N1-phenyl structures.

Miller MW, Mylari BL, Howes HL Jr, Lynch JE, Lynch MJ, Koch RC.

J Med Chem. 1979 Dec;22(12):1483-7.

PMID:
583429
16.
17.

The site of action of a broad-spectrum aryltriazine anticoccidial, CP-25,415.

Chappel LR, Howes HL, Lynch JE.

J Parasitol. 1974 Jun;60(3):415-20. No abstract available.

PMID:
4833852
18.

Novel anthelmintic agents. 6. Pyrantel analogs with activity against whipworm.

McFarland JW, Howes HL Jr.

J Med Chem. 1972 Apr;15(4):365-8. No abstract available.

PMID:
4623095
19.

Trans-1,4,5,6-tetrahydro-2-(3-hydroxystyryl)-1-methyl pyrimidine (CP-14,445), a new antiwhipworm agent.

Howes HL Jr.

Proc Soc Exp Biol Med. 1972 Feb;139(2):394-8. No abstract available.

PMID:
5059028
20.

Anthelmintic studies with pyrantel. II. Prophylactic activity in a mouse-ascaris suum test model.

Howes HL Jr.

J Parasitol. 1971 Jun;57(3):487-93. No abstract available.

PMID:
5090955
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk